BTG Pactual Global Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,748
Closed -$342K 132
2022
Q1
$342K Buy
+5,748
New +$367K 0.05% 114
2020
Q4
Sell
-11,940
Closed -$754K 117
2020
Q3
$754K Buy
+11,940
New +$828K 0.1% 111
2018
Q4
Sell
-3,145
Closed -$243K 48
2018
Q3
$243K Sell
3,145
-6,380
-67% -$482K 0.1% 54
2018
Q2
$675K Buy
9,525
+1,071
+13% +$75.6K 0.19% 47
2018
Q1
$637K Sell
8,454
-527
-6% -$41.9K 0.17% 47
2017
Q4
$643K Buy
8,981
+304
+4% +$23.1K 0.24% 37
2017
Q3
$703K Sell
8,677
-4,450
-34% -$340K 0.22% 43
2017
Q2
$929K Buy
13,127
+1,940
+17% +$129K 0.27% 46
2017
Q1
$760K Buy
+11,187
New +$787K 0.28% 51
2016
Q2
Sell
-2,374
Closed -$218K 48
2016
Q1
$218K Buy
+2,374
New +$214K 0.54% 31
2015
Q1
Sell
-4,400
Closed -$415K 182
2014
Q4
$415K Buy
4,400
+500
+13% +$51.7K 0.04% 121
2014
Q3
$416K Sell
3,900
-1,800
-32% -$176K 0.05% 130
2014
Q2
$473K Buy
5,700
+380
+7% +$29.6K 0.07% 164
2014
Q1
$377K Buy
5,320
+60
+1% +$4.71K 0.08% 128
2013
Q4
$395K Buy
+5,260
New +$366K 0.1% 94

Other funds holding GILD

BTG Pactual Global Asset Management's GILD Position: Q2 2022 in Review

BTG Pactual Global Asset Management sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 5,748 shares — an estimated $342K sold.

BTG Pactual Global Asset Management first reported a position in GILD in Q4 2013 and held it in 15 quarters. The position peaked at $929K in Q2 2017. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • BTG Pactual Global Asset Management reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 5,748 Gilead Sciences shares in Q2 2022, an estimated $342K.
  • BTG Pactual Global Asset Management first reported a position in Gilead Sciences in Q4 2013 and held it in 15 quarters.
  • BTG Pactual Global Asset Management's Gilead Sciences position peaked at $929K in Q2 2017.
  • 1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on BTG Pactual Global Asset Management's 13F filing for Q2 2022, filed 10 Aug 2022.